- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | DataMeds AI Aktie steigt nach Übernahme und neuem Webauftritt | 3 | Investing.com Deutsch | ||
| Mo | DataMEDS AI launches new corporate website following acquisition | 1 | Investing.com | ||
| Mo | DataMEDS AI, Inc.: DataMEDS AI Unveils New Corporate Website | 317 | ACCESS Newswire | Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement TAMPA, FL / ACCESS Newswire / September 21, 2026... ► Artikel lesen | |
| DATAMEDS AI Aktie jetzt für 0€ handeln | |||||
| Sa | Why DataMEDS' Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This Point | 3 | Barchart.com | ||
| Fr | DataMeds AI settles $19M debt litigation for $450K | 4 | Investing.com | ||
| Fr | DataMeds AI legt Rechtsstreit über 19-Millionen-Dollar-Schulden bei | 1 | Investing.com Deutsch | ||
| Fr | DataMEDS AI, Inc.: DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked | 343 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / September 18, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure... ► Artikel lesen | |
| 16.09. | DataMeds AI, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.09. | DataMEDS AI Stock Surges 452% After Completing Helomics Acquisition | 4 | RTTNews | ||
| 16.09. | DataMEDS AI Stock Soars 65% Pre-market: Here's What You Need to Know | 6 | Benzinga.com | ||
| 15.09. | DataMEDS AI, Inc.: DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute | 560 | ACCESS Newswire | Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer Management PITTSBURGH, PA / ACCESS Newswire / September 15, 2026 / DataMEDS AI, Inc. (NASDAQ:MEDS)... ► Artikel lesen | |
| 15.09. | Axe Compute Sells Helomics AI Cancer Diagnostics Business To DataMEDS AI, Becomes Pure-Play Neocloud GPU-as-a-Service Company | 2 | pulse2.com | ||
| 15.09. | Axe Compute Inc: Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform | 2 | GlobeNewswire (USA) | ||
| 08.09. | Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout | 1 | Insider Monkey | ||
| 08.09. | DataMEDS AI, Inc.: Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout | 415 | ACCESS Newswire | Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App TAMPA, FL /... ► Artikel lesen | |
| 27.08. | DataMEDS AI, Inc.: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid | 708 | ACCESS Newswire | 50% off available online at www.TolloHealth.Shop and www.CorexaRx.comSoon to become available at Health Lives Here pharmacies and on Amazon.com TAMPA, FL / ACCESS Newswire / August 27, 2026 / DataMeds... ► Artikel lesen | |
| 19.08. | DataMEDS AI reports Q2 results | 1 | Seeking Alpha | ||
| 18.08. | DataMeds AI, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 17.08. | DataMEDS AI, Inc.: DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update | 587 | ACCESS Newswire | Revenues grew 14% reaching $1.779M in Q2/26, beating management projectionsCorporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from... ► Artikel lesen | |
| 17.08. | DataMeds AI, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings |
1 2 3 4 5 Weiter >>
108 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ANBIO BIOTECHNOLOGY | 5,200 | +11,11 % | Anbio Biotechnology - 6-K, Report of foreign issuer | ||
| NASUS PHARMA | 3,520 | -1,12 % | Nasus Pharma, Ltd.: Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis | Clinical study to evaluate NS002, the Company's investigational intranasal epinephrine powder, as a needle-free alternative to EpiPen® for patients experiencing anaphylaxis and will compare self-administration... ► Artikel lesen | |
| KARDIGAN | 14,060 | -14,48 % | Citi's U.S. Consumer Cards Business To Buy Kard Financial For Undisclosed Terms | WASHINGTON (dpa-AFX) - Banking major Citigroup Inc. (C) announced late Thursday that its U.S. Consumer Cards business has agreed to acquire Kard Financial, a commerce media and rewards platform.... ► Artikel lesen | |
| BAYER | 49,380 | +0,14 % | Bayer präsentiert auf dem Gartner Supply Chain Planning Summit 2026, wie das Unternehmen seine globale Planung mit OMP neu aufgebaut hat | ANTWERPEN, BE / ACCESS Newswire / 17. September 2026 / OMP, ein führender Anbieter von
Supply-Chain-Planungslösungen, lädt die Teilnehmer des Gartner Supply Chain Planning... ► Artikel lesen | |
| MERCK KGAA | 133,95 | +0,75 % | Community-Rückblick: "Moderna wäre um min. 50% gestiegen, BioNTech bisher nicht mal 2%. That's it!" | © Foto: Julia Cebella - dpaNeue Onkologie-Daten sorgen bei BioNTech für Diskussionen: Warum reagiert die Aktie trotz guter Studienergebnisse kaum? Die wO User Diskutieren über Pipeline, Bewertung und... ► Artikel lesen | |
| NOVO NORDISK | 33,680 | -0,49 % | Novo Nordisk, BioNxt Solutions, Evotec - wenn aus Spritzen Tabletten werden, klingelt die Kasse | Die tägliche Spritze hat ihre besten Tage hinter sich. Biologika als Tablette zu schlucken galt lange als Utopie, seit diesem Jahr wird daraus ein Milliardengeschäft. Am 17. September 2026 gab Novo... ► Artikel lesen | |
| PFIZER | 25,090 | +1,41 % | Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick? | ||
| GENERATE BIOMEDICINES | 15,780 | -9,62 % | Generate Biomedicines auf dem Bernstein Healthcare Forum: Daten statt Modelle | ||
| ETON PHARMACEUTICALS | 58,72 | +2,86 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| SCHOTT PHARMA | 24,600 | +3,36 % | Schott Pharma: Was JPMorgans Kaufvotum jetzt auslöst | ||
| ELI LILLY | 1.029,60 | +1,74 % | Medtech vor Neubewertung: TempraMed zündet den Wachstumsturbo: Rekordumsätze, Humana-Deal und nur 28 Mio. CAD Börsenwert | ||
| AQUESTIVE THERAPEUTICS | 4,750 | -4,04 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm (dibutepinephrine) Sublingual Film | Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026FDA will determine the resubmission classification and establish the applicable... ► Artikel lesen | |
| JAGUAR HEALTH | 6,860 | -80,09 % | XFRA NEW INSTRUMENTS AVAILABLE ON 17.09.2026 | The following instruments on XETRA do have their first trading 17.09.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 17.09.2026
Aktien
1 CNE100007DY4 Shenzhen Woer Heat-Shrinkable... ► Artikel lesen | |
| DERMAPHARM | 39,300 | +0,13 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| LB PHARMACEUTICALS | 37,950 | -11,10 % | LB Pharmaceuticals auf TD Cowen Summit: Wirkstoffkandidat LB-102 zielt auf sicherere psychiatrische Behandlungen ab |
Das Unternehmen DATAMEDS AI INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell -16,73 % bei einem Aktienkurs von 3,560 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DATAMEDS AI INC finden Sie auf Wallstreet Online.